Consensus IDEXX Laboratories, Inc. Sao Paulo

Stocks

I1DX34

BRI1DXBDR001

Medical Equipment, Supplies & Distribution

Market Closed - Sao Paulo 15:37:02 2026-09-25 EDT			5-day change	1st Jan Change
538.10 ^BRL	-7.05%		+1.91%	-28.76%

09-17	Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Amid Economic Data, Fed Rate Hike	MT
09-17	IDEXX Laboratories Adds Taeniid Tapeworm Detection to Parasite Testing Platform	MT

3b96d5e.Jpu-THLwVJxRuH2q3by0eHflL-mT211F9Ka8uIj7Vm4.YvjHFTWeYK8Y4Q_Yr9-GCBSXRqGqhDkJgP7Jwr-ROSFCreoYA7MxpSD8KA~ad078daf9c4b8100bd4ed8d57665e4c4

Analysts' recommendations: IDEXX Laboratories, Inc.

08-11	Barclays Adjusts Price Target on IDEXX Laboratories to $710 From $800, Keeps Overweight Rating	MT
08-05	Jefferies Adjusts Price Target on IDEXX Laboratories to $795 From $792	MT
08-05	Citigroup Adjusts Price Target on IDEXX Laboratories to $670 From $650	MT
08-05	UBS Adjusts Price Target on IDEXX Laboratories to $670 From $620, Maintains Neutral Rating	MT
07-27	Elanco Seems Best-Positioned Into Q2 Print Among Animal Health Stocks, UBS Says	MT
07-27	UBS Cuts IDEXX Laboratories Price Target to $620 From $640, Maintains Neutral Rating	MT
07-13	Leerink Partners Adjusts IDEXX Laboratories Price Target to $715 From $725, Maintains Outperform Rating	MT
05-06	Rothschild & Co Redburn Adjusts Price Target on IDEXX Laboratories to $665 From $655	MT
05-06	Jefferies Adjusts Price Target on IDEXX Laboratories to $792 From $785	MT
04-28	UBS Adjusts Price Target on IDEXX Laboratories to $640 From $730, Maintains Neutral Rating	MT
04-27	Jefferies Adjusts Price Target on IDEXX Laboratories to $785 From $820, Maintains Buy Rating	MT
04-15	Citigroup Initiates IDEXX Laboratories at Neutral With $650 Price Target	MT
04-14	Leerink Partners Adjusts IDEXX Laboratories PT to $725 From $760, Maintains Outperform Rating	MT
03-31	Stifel Nicolaus Adjusts IDEXX Laboratories PT to $675 From $775, Maintains Buy Rating	MT
02-09	Piper Sandler Adjusts Price Target on IDEXX Laboratories to $750 From $775, Maintains Neutral Rating	MT
02-05	Barclays Adjusts Price Target on IDEXX Laboratories to $800 From $850, Maintains Overweight Rating	MT
02-04	Barclays Lowers Price Target on IDEXX Laboratories to $800 From $850	MT
02-03	Jefferies Adjusts Price Target on IDEXX Laboratories to $820 From $830	MT
02-03	UBS Adjusts IDEXX Laboratories PT to $730 From $750	MT
02-03	Leerink Partners Adjusts Price Target on IDEXX Laboratories to $760 From $785	MT
02-03	BTIG Adjusts Price Target on IDEXX Laboratories to $800 From $830	MT
02-03	Rothschild & Co Redburn Adjusts Price Target on IDEXX Laboratories to $655 From $700	MT
12-09	Barclays Initiates IDEXX Laboratories With Overweight Rating, $850 Price Target	MT
11-10	Piper Sandler Adjusts Price Target on IDEXX Laboratories to $775 From $700	MT
11-04	UBS Adjusts Price Target on IDEXX Laboratories to $750 From $710, Maintains Neutral Rating	MT